Deka Biosciences Stock

Early stage biotechnology company

Sign up today and learn more about Deka Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Deka Biosciences Stock

Early stage biotechnology start-up developing next generation cytokine therapeutics

Funding History

October 2021$20.0M
January 2022$21.5M
September 2023$20.0M

Management

Co-Founder, Chief Executive Officer

John Mumm

Board of Director

Detlev Biniszkiewicz

Co-Founder & CBO

Pavel Khrimian

Chief Operations Officer

John Conner

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo